A team of researchers from Purdue University withdrew its Novosteo project to the level of preclinical testing. They claim to have developed an innovative technology for affecting damaged bone without surgical intervention. Just a couple of injections – and cracks in the bones begin to tighten, and fractures grow together.
Since the Novosteo project is commercial, with very great potential, all the details are hidden under the veil of secrecy. There is no information about what substances are used for treatment, how they affect the bones, or at what speed the healing takes place. Moreover, until formal clinical trials are conducted, this is just an ambitious start-up with unknown safety parameters and scope of application.
But Novosteo's competitive advantage is well described. It is enough to inject the patient, anywhere, after which the active substance begins to circulate through the body, but accumulates only at the site of the injury. This will avoid problems with dosage and will simplify the treatment of patients.
Novosteo project authors see athletes and retirees among their top-priority clients. The former are often injured and should be rehabilitated as soon as possible and returned to the field. The latter often suffer from a fracture of the neck of the thigh – treatment in the form of injections would greatly simplify their life, in comparison with traditional methods.js.src = “&version=v2.8”; 'script', 'facebook-jssdk'));